Red light therapy after surgery targets the biological processes that determine whether recovery goes smoothly or turns into weeks of lingering pain, a wound that won't finish closing, and a bottle of opioid painkillers that keeps needing refills. For the roughly one in nine Americans who undergo at least one surgical procedure in any given year (Bicket et al., 2024), what happens after the incision closes matters as much as the surgery itself.
That pattern of difficult recovery is not rare. A 2024 JAMA Network Open analysis of more than one million surgical procedures (Alessio-Bilowus et al.) found that roughly 40% of all prescribed opioids in the United States relate to surgical care, with knee arthroplasty alone accounting for approximately 10% of all postoperative opioid consumption in adults aged 45 to 64. Among older adults, surgery is more frequent still: 8.8 major procedures per 100 person-years in adults aged 65 and over, peaking at 10.8 in the 75-to-79 age group (Becher et al., 2023). The older the patient, the more surgeries they face, and the harder each recovery becomes.
Behind those numbers is a biological reality. Surgery creates tissue trauma, and the body repairs it through cellular processes: inflammation resolution, new blood vessel formation, collagen synthesis, and tissue remodeling. When those processes are impaired by age, diabetes, poor circulation, or the sheer extent of surgical damage, recovery stalls. Pain persists. Wounds heal slowly, or not at all.
Red and near-infrared light therapy, clinically known as photobiomodulation, works at precisely that cellular level. It delivers specific wavelengths of light that penetrate tissue and activate biological processes involved in healing and pain reduction. The evidence now includes the largest meta-analysis ever conducted on near-infrared therapy for surgical wound healing (Liu et al., 2026): 56 randomized controlled trials enrolling 4,920 patients, registered with PROSPERO. The review found that photobiomodulation significantly improved wound healing and significantly reduced postoperative pain. The meta-analysis rated overall certainty of evidence as very low per the GRADE framework, largely due to high heterogeneity across studies (I² = 89.2%) and inconsistent effects on secondary outcomes including swelling, scarring, and inflammatory markers. Despite these limitations, the direction and magnitude of the primary findings were consistent across surgical types, spanning orthopedic joint replacement, cardiac bypass surgery, dental and oral surgery, cesarean delivery, hernia repair, fracture surgery, and scar prevention.
Key Takeaways
- The 2026 Liu et al. meta-analysis, the largest to date on surgical wound healing, pooled 56 randomized controlled trials (N = 4,920) and found that near-infrared therapy significantly improved wound healing (standardized mean difference 0.78, p < 0.01) and significantly reduced postoperative pain (SMD 0.71, p < 0.01). Optimal outcomes were associated with wavelengths of 700–850 nm, four to ten treatment sessions, and non-contact application. The GRADE-assessed certainty of evidence was very low due to high heterogeneity, indicating that while the overall direction of effect is positive, definitive conclusions require further standardized research.
- In a head-to-head randomized trial against ibuprofen 600 mg (Nunes et al., 2020), a single session of photobiomodulation produced significantly lower pain scores at 24 hours (p < 0.001) in patients after dental surgery. Separate randomized trials after knee arthroplasty and fracture surgery found that patients receiving photobiomodulation consumed 20–42% fewer opioid painkillers than controls.
- A Level I double-blind, sham-controlled randomized trial (Abufoul et al., 2023) found that patients who self-applied photobiomodulation at home after rotator cuff arthroscopic surgery experienced significantly faster improvements in pain, shoulder function, and quality of life compared to the sham group, with the treatment accelerating recovery within the first six months.
- Red light therapy after surgery works through nine biological mechanisms that address the root causes of delayed recovery: reducing pain through multiple non-opioid pathways including activation of the body's own opioid system, controlling post-surgical inflammation, reprogramming immune cells from destruction to repair, accelerating wound closure, reducing swelling and edema, restoring cellular energy for repair, defending against oxidative stress, promoting blood flow to healing tissue, and minimizing scar formation.
What Happens After Surgery, and Why Recovery Isn't Always Straightforward
Surgery is controlled trauma. No matter how precise the technique, the act of cutting through skin, muscle, bone, or organ tissue triggers a cascade of biological responses. Inflammation floods the surgical site. Blood vessels are disrupted. Tissue is damaged, and the body must rebuild what was cut.
In an ideal recovery, the body moves through three overlapping phases. In the inflammatory phase, immune cells rush to the surgical site to clear damaged tissue and prevent infection. In the proliferative phase, new blood vessels form to supply oxygen and nutrients while fibroblasts lay down collagen scaffolding and new tissue gradually fills the wound. In the remodeling phase, that initial repair tissue is restructured into something stronger and more organized over weeks to months.
When this process works, surgical incisions heal, pain subsides, swelling resolves, and function returns within a predictable timeframe. When it doesn't, patients face prolonged pain that requires escalating doses of medication, wounds that close slowly and stay vulnerable to infection, scarring thick enough to restrict movement, and a recovery timeline that stretches well beyond what anyone prepared for.
Several factors commonly disrupt post-surgical healing. Older age means slower cellular activity and weaker blood vessel formation. Diabetes impairs circulation, immune response, and the fibroblast activity that builds new tissue. Obesity increases wound tension and reduces oxygen delivery. The type and extent of surgery matters too: a total knee replacement creates far more tissue trauma than a dental extraction, and the depth and location of the incision determine how much repair work the body must do.
What all these risk factors share is that they act at the cellular level. They leave the cells responsible for repair with less energy, fewer resources, and a diminished ability to do their job. Conventional post-surgical care manages the situation from the outside. Pain medication blocks the perception of pain. Anti-inflammatory drugs suppress the inflammatory response. Wound care tends the surface while the cellular repair underneath determines whether the wound actually closes. These interventions are essential, but they cannot drive the repair process itself. They manage what is happening to the body. They do not speed up what the body is doing.
Red light therapy works directly on the cellular processes that conventional post-surgical care depends on.
Standard post-surgical care is effective. Good pain management, wound monitoring, physical therapy: these are the foundation of recovery, and for most patients, they're enough. Where I see patients struggle is when the biology of healing is compromised. The patient is older, or diabetic, or the tissue damage was extensive, and the cells at the surgical site don't have the energy to keep up. What makes the photobiomodulation research worth paying attention to is that it appears to work at that level, on the cellular energy production and the inflammatory signaling that determine whether tissue actually repairs. That's a gap in the post-surgical toolkit we haven't had a good answer for.— Dr. William Carter, MD
How Red Light Therapy Accelerates Post-Surgical Recovery: Nine Biological Mechanisms
Red and near-infrared light in the 630–850 nm wavelength range penetrates through skin and into the tissue beneath. There, it is absorbed by a specific protein inside the mitochondria called cytochrome c oxidase, the cell's primary light-absorbing molecule in this wavelength range. That absorption event triggers a cascade of biological responses directly relevant to surgical recovery. For a detailed explanation of how this process works, see our article on how red light therapy works at the cellular level.
Reducing Post-Surgical Pain Through Multiple Non-Opioid Pathways
Post-surgical pain is not just a quality-of-life issue. It drives opioid prescriptions, delays rehabilitation, impairs sleep, and slows the biological processes of healing itself. Opioid painkillers, the standard response, carry well-documented risks: dependence, tolerance, constipation, nausea, respiratory depression, and refill rates that can exceed one-third for high-demand surgeries such as spine and knee arthroplasty.
Red light therapy reduces post-surgical pain through three distinct pathways.
The first is anti-inflammatory. By lowering the inflammatory mediators that activate pain-sensing nerve fibers at the surgical site, the therapy reduces the chemical source of the pain signal. Tomazoni et al. (2021) demonstrated this in a randomized, triple-blinded, placebo-controlled trial: a single session of photobiomodulation significantly reduced prostaglandin E2, one of the primary molecules driving inflammatory pain, compared to placebo in patients with chronic musculoskeletal pain. The trial was conducted in chronic low back pain patients rather than surgical patients specifically, but prostaglandin E2 drives pain signaling at surgical wound sites through the same pathway.
The second is direct neural modulation. Red and near-infrared light raises the firing threshold of nociceptive nerve fibers and slows the transmission of pain signals, an effect independent of any anti-inflammatory drug. Buzza et al. (2024) showed in Lasers in Surgery and Medicine that photobiomodulation can selectively inhibit small-diameter pain fibers while preserving large-fiber function, producing a targeted analgesic effect lasting hours to days (Evidence tier: preclinical, animal model). The mechanism is consistent with the clinical pain relief observed in human surgical trials.
The third is endogenous opioid activation. In a rat model, Pereira et al. (2017) found that photobiomodulation-induced pain relief could be blocked by naloxone, a drug that specifically antagonizes opioid receptors. The finding indicates that photobiomodulation activates the body's own opioid system, providing pain relief through the same biological pathway that pharmaceutical opioids target, but without the risks of dependence, tolerance, or respiratory depression (Evidence tier: preclinical). Cheng et al. (2021) confirmed all three pathways in a review published in The Journal of Pain.
The clinical results in surgical patients are consistent with these mechanisms. After endodontic treatment, Nunes et al. (2020) randomized 70 patients to either a single session of photobiomodulation or two doses of ibuprofen 600 mg. A single operator performed all treatments, and a separate blinded researcher evaluated pain at 6, 12, 24, and 72 hours. At 24 hours, the photobiomodulation group reported significantly lower pain (p < 0.001). After total knee arthroplasty, patients in the laser group of a three-arm randomized trial (Bahrami et al., 2023) consumed 20% fewer opioid painkillers than controls (48.3 mg versus 60.3 mg oxycodone, p = 0.02). The largest reduction came after tibial fracture surgery (Nesioonpour et al., 2014): the laser group consumed 42% fewer opioids (51.62 mg versus 89.28 mg, p = 0.008), with significantly lower pain scores at every measurement point from 2 to 24 hours.
The Liu et al. 2026 meta-analysis confirmed this pattern across surgical types: near-infrared therapy significantly reduced postoperative pain (SMD 0.71, p < 0.01) in the pooled analysis of randomized controlled trials.
Controlling Post-Surgical Inflammation
Surgery triggers an acute inflammatory response that is necessary in the short term: it clears damaged tissue and initiates repair. But when inflammation persists beyond its useful window, it becomes the primary obstacle to recovery. Prolonged inflammation degrades the collagen that fibroblasts are trying to build, damages newly forming blood vessels, and keeps the wound locked in the destructive phase instead of progressing to rebuilding.
Red light therapy modulates post-surgical inflammation at the molecular level. In a triple-blind, placebo-controlled trial after total hip arthroplasty (Langella et al., 2018), 18 patients received either active photobiomodulation or placebo within 8 to 12 hours of surgery. The treatment used a multi-diode device combining super-pulsed 905 nm laser, 875 nm infrared LEDs, and 640 nm red LEDs, applied to five points along the incision. The photobiomodulation group showed significantly reduced serum levels of TNF-α and IL-8 (p < 0.05), two key inflammatory cytokines that drive post-surgical tissue damage and pain. Those reductions occurred after a single treatment session.
At the cellular level, Lim et al. (2013) traced part of the mechanism: 635 nm red light switched off NF-κB, a master inflammatory signaling pathway, in human gingival fibroblast cells, acting through heat shock protein 27, which functions as a brake on runaway inflammation.
The inflammatory response is the body's first reaction to surgery, and it sets the stage for everything that follows. When photobiomodulation helps resolve that inflammation on schedule, the downstream repair processes can begin.
For more on how red light therapy modulates inflammation at the cellular level, see our dedicated article on red light therapy for inflammation.
Reprogramming Immune Cells from Destruction to Repair
Beyond reducing inflammatory signals, red light therapy changes how immune cells behave at the surgical site. The most critical example for wound healing is macrophage polarization. Macrophages are immune cells that exist on a spectrum between two functional states: M1, which is pro-inflammatory and tissue-destroying, and M2, which is anti-inflammatory and tissue-repairing. In wounds where the inflammatory phase persists too long, macrophages remain stuck in the M1 state, perpetuating damage and blocking the transition to rebuilding.
Hamblin (2017) documented in a comprehensive mechanistic review for AIMS Biophysics that photobiomodulation reduces markers of the destructive M1 state and promotes the shift toward the M2 repair phenotype, in a wavelength- and dose-dependent manner. A review of 19 studies by Ferreira et al. (2025) in Lasers in Medical Science confirmed the pattern across the 630–890 nm range, with light reliably promoting M2 and suppressing M1 through several known signaling pathways. More recently, a 2026 study in Advanced Science (Shi et al.) demonstrated in both cell culture and live wounds that 850 nm near-infrared light changed how macrophages burned fuel and reshaped their mitochondria, pushing them toward the repairing state and speeding tissue repair. When the researchers blocked the metabolic changes the light triggered, the shift reversed, confirming cause and effect.
The transition from the inflammatory phase to the proliferative phase of wound healing depends on macrophages making this M1-to-M2 switch. In patients where surgery is extensive, or where diabetes or age impairs immune regulation, the transition can stall. Photobiomodulation helps drive it forward.
Accelerating Wound Closure and Tissue Repair
The speed at which a surgical wound closes depends on the cells responsible for building new tissue: fibroblasts producing collagen, keratinocytes migrating across the wound surface, and endothelial cells forming the new blood vessels that supply the repair site with oxygen. In older patients, diabetic patients, and those recovering from extensive surgery, all of these cellular activities are impaired.
Red light therapy directly stimulates the proliferation and migration of these repair cells. A systematic review of 27 experimental studies (Da Rocha et al., 2024) confirmed that LED-based photobiomodulation boosted cell proliferation, cell migration, new blood vessel formation, and collagen deposition across wound models, with red wavelengths especially effective.
The clinical evidence in surgical wounds is now anchored by the Liu et al. 2026 meta-analysis. Across 56 randomized controlled trials and 4,920 patients with surgical or postoperative wounds, near-infrared therapy significantly improved wound healing outcomes (SMD 0.78, p < 0.01). The meta-analysis used PROSPERO-registered methodology, assessed risk of bias using Cochrane RoB 2.0, and rated certainty of evidence using the GRADE framework (very low, primarily due to high heterogeneity across the included studies).
In specific surgical settings, the wound healing data is detailed. After cesarean section, a randomized clinical study (Dehghanpour et al., 2023) of 40 patients found that REEDA wound healing scores were significantly better in the photobiomodulation group at day 3 (p = 0.035), day 7 (p = 0.03), and day 10 (p = 0.02). By day 10, the mean healing score in the treated group was less than half that of the control group (1.09 versus 2.25). After coronary artery bypass surgery, a four-arm randomized, double-blind study of 120 patients (Lima et al., 2017) found that both laser and LED photobiomodulation significantly reduced wound hyperemia and dehiscence at the sternotomy site (p ≤ 0.005), including in hyperglycemic patients whose healing is typically compromised.
For a comprehensive review of how red light therapy supports wound healing across all wound types, see our article on red light therapy for wound healing.
Reducing Swelling and Edema
Post-surgical swelling is one of the most common and functionally limiting complications of surgery. In joint surgery, edema restricts range of motion and delays rehabilitation. Oral surgical patients face trismus (limited mouth opening) that impairs eating and speaking. Cosmetic procedures carry their own version of the problem: visible swelling that prolongs the recovery period well beyond the point where the surgical work itself has healed.
The evidence for photobiomodulation in reducing post-surgical edema is strong. A systematic review and meta-analysis of 33 randomized controlled trials involving 1,347 patients (Lacerda-Santos et al., 2023) focused specifically on edema, pain, and trismus after third molar surgery. The results showed significant edema reduction at day 2 (SMD −0.61, p < 0.001) and significant pain reduction at day 3 (SMD −1.09, p < 0.001).
In orthopedic surgery, the functional impact of edema reduction has been measured directly. A randomized clinical trial of 30 patients after total knee arthroplasty (Chia et al., 2025) found that photobiomodulation reduced post-surgical swelling as measured by bioimpedance and improved the two-minute walk distance (27 meters versus 16 meters in the control group). The Bahrami et al. (2023) three-arm trial similarly found that the laser group achieved significantly higher range of motion at three months after total knee arthroplasty (116.8° versus 104.0° versus 92.3° for laser, light therapy, and control groups, p < 0.001).
Swelling may seem like a secondary concern next to pain and wound healing, but in joint surgery particularly, edema is what stands between a patient and the rehabilitation exercises that determine their long-term outcome.
Restoring Cellular Energy for Repair
Every step of surgical recovery runs on cellular energy. Immune cells need adenosine triphosphate (ATP) to clear the wound bed. Fibroblasts need it to produce collagen. Keratinocytes need it to migrate across the wound surface, and endothelial cells need it to build new blood vessels. When the cells at a surgical site run low on energy, as they do in aged tissue, diabetic tissue, or tissue that has been extensively traumatized, recovery slows across every dimension simultaneously.
Red and near-infrared light is absorbed by cytochrome c oxidase, the terminal enzyme in the mitochondrial electron transport chain. The cell responds by producing more ATP. Wong-Riley et al. (2005) demonstrated this in a landmark study published in The Journal of Biological Chemistry: LED light at 670 nm and 830 nm restored cytochrome c oxidase activity and ATP production in neurons whose energy systems had been shut down by metabolic toxins. The most effective wavelengths matched the absorption peaks of the oxidized form of the enzyme, confirming it as the primary photoreceptor.
The effect has been measured in living human tissue. Using phosphorus-31 magnetic resonance spectroscopy, Fear et al. (2023) tracked ATP synthesis in the brains of older adults before and after a session of transcranial photobiomodulation at 670 nm. They recorded a significant increase in the rate of ATP synthase flux after a single treatment. A cell that cannot produce enough energy cannot divide, migrate, build collagen, or resolve inflammation. Restoring its energy production restores its capacity to participate in repair.
Defending Against Oxidative Stress at the Surgical Site
Surgery generates a burst of oxidative stress at the wound site. Reactive oxygen species are produced both by the tissue trauma itself and by the immune cells that flood the area during the inflammatory phase. When this oxidative burden overwhelms the body's antioxidant defenses, it damages the very cells trying to repair the wound and can keep the inflammatory phase going longer than it should.
Red light therapy has a nuanced, context-dependent relationship with oxidative stress. In cells already under oxidative burden, as in surgical wounds, photobiomodulation reduces harmful oxidative molecules and strengthens antioxidant capacity. Tomazoni et al. (2019) ran a randomized controlled trial on elite soccer players, published in Oxidative Medicine and Cellular Longevity, and found that a single pre-exercise session of photobiomodulation significantly increased antioxidant enzyme activity and decreased markers of oxidative damage compared to placebo. A systematic review by Dos Santos et al. (2017) analyzed photobiomodulation's effects across multiple animal models of muscle injury and confirmed consistent reductions in oxidative damage markers alongside increases in antioxidant enzyme activity.
These studies were conducted in exercise-induced contexts rather than surgical ones, but the oxidative stress pathways are shared. The mechanism provides additional biological basis for photobiomodulation's tissue-protective effects after surgery.
Promoting Blood Flow to Healing Tissue
Oxygen and nutrients reach the surgical site through blood vessels. When those vessels have been disrupted by surgery, or when the patient has underlying circulatory impairment, inadequate blood supply becomes a primary reason healing stalls.
Red light therapy drives blood flow improvement through two routes. The rapid effect operates through nitric oxide. When near-infrared light strikes cytochrome c oxidase, it releases nitric oxide molecules that were previously bound to the enzyme. These molecules diffuse into surrounding tissue and relax blood vessel walls, increasing flow. A randomized controlled trial (Gavish et al., 2020) captured the result: near-infrared light raised microcirculatory blood flow by 27% immediately, and the effect continued climbing to 54% over the twenty minutes following treatment.
Beyond that immediate vasodilation, photobiomodulation stimulates angiogenesis: the formation of entirely new blood vessels into healing tissue. Cury et al. (2013) found in an ischemic tissue model that low-level laser therapy raised the primary blood vessel growth factor (VEGF) and the master hypoxia-response signal (HIF-1α), and new vessels followed. For surgical wounds in patients with compromised circulation, this mechanism addresses one of the most fundamental barriers to recovery: the tissue cannot heal if blood cannot reach it.
Minimizing Post-Surgical Scarring
Every surgical incision produces a scar. The quality of that scar, its thickness, pliability, color, and overall cosmetic appearance, depends on the balance between collagen production and collagen remodeling in the weeks and months after surgery. When that balance tips toward excessive production with poor organization, the result is a thick, raised, rigid scar. When the destructive matrix metalloproteinase enzymes overpower collagen production, the result is a fragile scar that breaks down easily.
Red light therapy acts on both sides of this balance. Ayuk et al. (2018) found that photobiomodulation lowered matrix metalloproteinases (the enzymes that break tissue down) while raising tissue inhibitors of metalloproteinases (the proteins that protect it) in stressed skin fibroblast cells. This shifts the wound environment toward controlled, organized collagen remodeling.
The clinical scar data supports this mechanism. In a randomized controlled trial after inguinal hernia repair (Carvalho et al., 2010), 28 patients were randomized to photobiomodulation or control. At six months, the laser group had significantly better Vancouver Scar Scale scores (2.14 versus 4.85), significantly less scar thickness (0.11 cm versus 0.19 cm), better malleability, and approximately 50% less pain at the scar site. A scoping review of post-surgical and burn scars (Gaumond et al., 2026) covering seven clinical studies and 297 patients found that red LED improved Vancouver Scar Scale scores, pigmentation, and thickness in burn scars, while near-infrared photobiomodulation improved scars after hernia repair, thyroidectomy, and blepharoplasty. The treatment was well tolerated across all studies.
Does Red Light Therapy Work After Surgery? What Clinical Trials Show
Red light therapy's effects on post-surgical recovery have now been tested in multiple meta-analyses and dozens of randomized controlled trials across surgical specialties. The results are consistent.
Surgical Wound Healing Overall
The Liu et al. (2026) meta-analysis is the anchor finding. Registered with PROSPERO (CRD420251163415), it searched multiple databases using standardized methodology and included 56 randomized controlled trials enrolling 4,920 patients. Thirty-five trials contributed 69 outcomes to the quantitative meta-analysis. Near-infrared therapy in the 630–1100 nm range significantly improved wound healing (SMD 0.78, 95% CI 0.46–1.09, p < 0.01) and significantly reduced postoperative pain (SMD 0.71, 95% CI 0.24–1.17, p < 0.01) compared to standard care or placebo. Risk of bias was assessed using Cochrane RoB 2.0 and certainty of evidence was rated using the GRADE framework. The overall GRADE rating was very low, primarily because of substantial heterogeneity (I² = 89.2%) across the included studies, which used varying wavelengths, doses, and treatment schedules, and because effects on secondary outcomes (swelling, scarring, inflammatory markers) were inconsistent. Moderator analyses identified short wavelengths (700–850 nm), four to ten sessions, and non-contact application as the parameters associated with the best outcomes.
Orthopedic Surgery
Orthopedic procedures generate some of the highest post-surgical pain burdens and longest rehabilitation timelines of any surgical category. The evidence for photobiomodulation here includes two of the strongest individual trials in the literature.
After total knee arthroplasty, a three-arm randomized trial (Bahrami et al., 2023) compared 804 nm laser therapy, Bioptron light therapy, and controls in 45 patients. The laser group achieved significantly higher range of motion at three months (116.8° versus 92.3° in controls, p < 0.001), significantly lower pain scores, significantly fewer opioid painkillers consumed (48.3 mg versus 60.3 mg oxycodone, p = 0.02), and Knee Society Scores that exceeded the minimum clinically important difference. The authors rated the evidence Level I.
After rotator cuff arthroscopic surgery, a double-blind, sham-controlled randomized trial (Abufoul et al., 2023) enrolled 50 patients (mean age 55, male-to-female ratio 29:21) and randomized them to active or sham 808 nm photobiomodulation devices for self-application at home. The active group showed significantly accelerated improvement in pain, shoulder function (QuickDASH, p = 0.029), and quality of life (SF-12 physical component p = 0.031, mental component p = 0.032) within the first six months. This trial is directly relevant to the home-use context: the patients applied the treatment themselves, with a portable device, as part of their standard rehabilitation.
A 2025 randomized trial after total knee arthroplasty (Chia et al.) added swelling-specific data: photobiomodulation reduced postoperative swelling measured by bioimpedance and improved the two-minute walk distance (27 meters versus 16 meters), demonstrating functional recovery gains beyond pain reduction alone.
Oral and Dental Surgery
Dental and oral surgery has the largest volume of randomized evidence for photobiomodulation of any surgical specialty. A 2023 meta-analysis of 33 randomized controlled trials (Lacerda-Santos et al.) enrolling 1,347 patients found significant pain reduction at day 3 (SMD −1.09, p < 0.001) and significant edema reduction at day 2 (SMD −0.61, p < 0.001) after third molar surgery. A separate systematic review of 18 randomized controlled trials involving 771 patients (Chaple Gil et al., 2025) reported 30–55% pain reduction within three to seven days, along with reductions in TNF-α and IL-6 and increased VEGF, the growth factor responsible for new blood vessel formation.
The head-to-head comparison against medication stands out. Nunes et al. (2020) randomized 70 patients to photobiomodulation or ibuprofen 600 mg after endodontic treatment. A single operator performed all treatments using a reciprocal system, and a separate blinded researcher evaluated pain at 6, 12, 24, and 72 hours. A single session of photobiomodulation produced significantly lower pain scores than ibuprofen at 24 hours (p < 0.001).
After oral mucosal surgery, a meta-analysis of 12 randomized controlled trials (Seyyedi et al., 2022) found significant improvement in wound epithelialization (MD −0.28, p < 0.001) and significant pain reduction at day 7 (MD −0.47, p < 0.001) and day 14 (MD −0.55, p = 0.005). After gingival surgery specifically, a separate meta-analysis of 12 studies (Ebrahimi et al., 2021) found that the Landry healing index was significantly improved at day 7 (SMD 1.044, p < 0.01), and complete wound epithelialization tripled at day 14 (risk ratio 3.23, p < 0.01).
Cardiac Surgery
Coronary artery bypass grafting is one of the most common cardiac surgeries worldwide and carries significant risk of postoperative complications. A randomized controlled trial enrolling 192 patients (Kazemi Khoo et al., 2021), of whom 170 completed the study, used a combined protocol of intravenous photobiomodulation (405 nm) and transdermal photobiomodulation (980 nm). The study was open-label rather than blinded, which is a limitation for subjective outcomes. The photobiomodulation group had significantly lower cardiac damage enzymes (LDH, CPK at day 4, p < 0.05), significantly lower pain scores on the visual analog scale, and significantly fewer complications, including pericardial effusion, heart failure, rehospitalization, and mediastinitis (all p < 0.05). Because this study used intravenous laser delivery, the results reflect a specialized clinical protocol rather than a home-use application.
For sternotomy wound healing specifically, a four-arm randomized, double-blind study of 120 patients (Lima et al., 2017) compared laser, LED, combined, and control groups after coronary bypass surgery. Both laser and LED groups showed significantly less wound hyperemia and less dehiscence (p ≤ 0.005). The results held in hyperglycemic patients, a population in which wound healing is characteristically impaired.
Obstetric Surgery
Cesarean section is the most common major surgical procedure in many countries. A randomized clinical study of 40 patients (Dehghanpour et al., 2023) evaluated photobiomodulation after cesarean delivery and found that REEDA wound healing scores were significantly better in the treated group at day 3 (p = 0.035), day 7 (p = 0.03), and day 10 (p = 0.02). At day 10, the intervention group's mean healing score was less than half that of the control group (1.09 versus 2.25). A separate safety study (Mokmeli et al., 2009) confirmed that post-cesarean photobiomodulation did not compromise blood prolactin levels or lactation status, establishing safety in the postpartum context.
For episiotomy and perineal recovery, a randomized clinical trial (de Constant Boniatti et al., 2024) compared photobiomodulation directly against cryotherapy, the most commonly used physical modality for perineal pain, in 56 women with grade I or II lacerations or episiotomy. The photobiomodulation group had significantly lower pain scores and less vulvar edema. This is the first head-to-head evidence that photobiomodulation can outperform the current standard physical treatment in this population. Additional positive individual randomized trials support photobiomodulation for episiotomy pain relief and wound healing, though the total evidence base for this specific indication is still growing.
Fracture Surgery and General Surgery
After tibial fracture surgery, a double-blind controlled randomized trial of 54 patients (Nesioonpour et al., 2014) found that the laser group had significantly less pain at every measurement point from 2 to 24 hours post-surgery (all p < 0.05) and consumed 42% fewer opioid painkillers (51.62 mg versus 89.28 mg, p = 0.008). A meta-analysis of randomized trials on fracture healing (Neto et al., 2020) provided further support for photobiomodulation's role in accelerating fracture repair.
After inguinal hernia repair, the Carvalho et al. (2010) randomized trial found that photobiomodulation significantly improved scar quality, thickness, malleability, and pain at six months. For a surgery performed on millions of patients annually, small improvements in scar quality and residual pain matter at scale.
Which Types of Surgery Have the Strongest Evidence, and Where Is the Evidence Still Building?
Strong evidence (meta-analyses with large patient pools): Oral and dental surgery has the deepest evidence base, with multiple independent meta-analyses each enrolling over 1,000 patients and consistently finding significant benefits for pain, edema, trismus, and wound healing. Surgical wound healing broadly is supported by the Liu et al. 2026 meta-analysis of 56 trials and 4,920 patients, though the GRADE-assessed certainty is very low due to heterogeneity.
Strong evidence (Level I randomized trials): Orthopedic surgery (total knee arthroplasty and rotator cuff repair) is supported by Level I randomized trials with meaningful clinical outcomes: reduced opioid consumption, improved range of motion, and accelerated functional recovery. Cardiac surgery is supported by a 192-patient randomized trial (open-label) with significant reductions in complications and cardiac enzyme markers, and a separate double-blind 120-patient trial confirming sternotomy wound healing benefits.
Promising and building: Obstetric surgery (cesarean and episiotomy) is supported by positive individual randomized trials with significant wound healing and pain outcomes. Post-surgical scar prevention is supported by individual randomized trials and a scoping review with consistently positive findings, though the total patient pool is smaller than the dental evidence. Burn surgery is supported by early randomized trials with positive results. Fracture healing acceleration has meta-analytic support with positive signals.
What Has Not Been Tested
The evidence for red light therapy after surgery is substantial and growing rapidly. Several areas remain open.
No single large-scale, multicenter trial has tested a standardized photobiomodulation protocol across multiple surgical specialties with a unified control arm. The existing evidence is strong within surgical categories but uses varying wavelengths, doses, and treatment schedules across studies. The Liu et al. meta-analysis identified 700–850 nm wavelengths and four to ten sessions as optimal moderators, but a definitive dose-response protocol for each surgery type has not been established. The very low GRADE certainty rating reflects this heterogeneity more than it reflects any absence of effect: the treatment consistently outperformed controls, but with wide variation in magnitude.
The interaction between photobiomodulation and other post-surgical interventions, such as negative pressure wound therapy, enhanced recovery after surgery (ERAS) protocols, or multimodal analgesia regimens, is under active investigation. A registered randomized controlled trial (NCT05738239) is currently testing photobiomodulation combined with multimodal analgesia after cesarean section, but results are not yet available. Because photobiomodulation works through different biological pathways than pharmacological interventions, combination approaches may produce additive benefits, but the clinical data to confirm this is still emerging.
Long-term scar outcomes beyond six months are underreported. The Carvalho et al. trial followed patients to six months with positive results, but the scar remodeling phase continues for up to two years. Whether early photobiomodulation produces durable improvements in final scar quality is a question the current literature can suggest but not definitively answer.
Head-to-head comparisons against cryotherapy are limited. One randomized trial in episiotomy recovery (de Constant Boniatti et al., 2024) found photobiomodulation superior to cryotherapy for pain and edema, but this was a single small trial (n = 56) in an obstetric population. Direct comparisons in orthopedic, dental, or general surgical recovery remain a gap in the evidence.
Conclusion
Surgical recovery is not passive. It is an active biological program that requires cellular energy, organized inflammation, immune cell reprogramming, blood vessel growth, collagen production, and coordinated pain resolution. When any of these processes is impaired, recovery stalls.
Red and near-infrared light therapy acts on nine distinct mechanisms that directly support this program. It does not replace wound management, rehabilitation, or appropriate pain medication; it supports the cellular processes that all of those depend on. The clinical evidence, now anchored by a PROSPERO-registered meta-analysis of 56 randomized controlled trials, consistently shows that photobiomodulation accelerates wound healing, reduces pain, decreases swelling, lowers opioid consumption, and improves functional outcomes after surgery. In a Level I trial, patients self-applied the therapy at home with a portable device and achieved significant improvements in recovery.
The evidence is substantial, the safety profile is well established, and the biological rationale is clear. For anyone preparing for surgery or managing a recovery that has been slower than expected, this is information worth having when deciding how to support the healing process.
